These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25678860)

  • 1. Human-derived natural antibodies: biomarkers and potential therapeutics.
    Xu X; Ng SM; Hassouna E; Warrington A; Oh SH; Rodriguez M
    Future Neurol; 2015; 10(1):25-39. PubMed ID: 25678860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion.
    Baumgarth N; Tung JW; Herzenberg LA
    Springer Semin Immunopathol; 2005 Mar; 26(4):347-62. PubMed ID: 15633017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse.
    Piganelli JD; Poulin M; Martin T; Allison JP; Haskins K
    J Autoimmun; 2000 Mar; 14(2):123-31. PubMed ID: 10677243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A substantial proportion of the adult BALB/c available B cell repertoire consists of multireactive B cells.
    Rousseau PG; Mallett CP; Smith-Gill SJ
    Mol Immunol; 1989 Oct; 26(10):993-1006. PubMed ID: 2594017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and spectrum of autoimmunity.
    Perl A
    Methods Mol Biol; 2012; 900():1-9. PubMed ID: 22933062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could DNA-reactive B lymphocytes be activated through HIV-1 DNA-stimulation involving BCR/TLR-9 pathway to yield antibodies targeting viral DNA?
    Norelli S
    Med Hypotheses; 2014 Dec; 83(6):659-63. PubMed ID: 25441838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Immunobiology; 2016 Sep; 221(9):1014-33. PubMed ID: 27262513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
    Kinzel S; Lehmann-Horn K; Torke S; Häusler D; Winkler A; Stadelmann C; Payne N; Feldmann L; Saiz A; Reindl M; Lalive PH; Bernard CC; Brück W; Weber MS
    Acta Neuropathol; 2016 Jul; 132(1):43-58. PubMed ID: 27022743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial autoimmunity participates in the regulation of rheumatoid arthritis.
    Zohar Y; Wildbaum G; Karin N
    Front Biosci; 2006 Jan; 11():368-79. PubMed ID: 16146738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.
    Becher B; Bechmann I; Greter M
    J Mol Med (Berl); 2006 Jul; 84(7):532-43. PubMed ID: 16773356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the immune response by natural IgM: lessons from warm autoimmune hemolytic anemia.
    Stahl D; Sibrowski W
    Curr Pharm Des; 2003; 9(23):1871-80. PubMed ID: 12871191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of T-cell-mediated mechanisms in virus infections of the nervous system.
    Dörries R
    Curr Top Microbiol Immunol; 2001; 253():219-45. PubMed ID: 11417137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How the immune system achieves self-nonself discrimination during adaptive immunity.
    Jiang H; Chess L
    Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responses.
    Sedimbi SK; Hägglöf T; Garimella MG; Wang S; Duhlin A; Coelho A; Ingelshed K; Mondoc E; Malin SG; Holmdahl R; Lane DP; Leadbetter EA; Karlsson MCI
    Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9054-9063. PubMed ID: 32295878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reactive anti-class II T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polycolonal activation and transfer autoimmunity in CD8-depleted normal syngeneic recipients.
    Saoudi A; Castedo M; Nochy D; Mandet C; Pasquier R; Druet P; Pelletier L
    Eur J Immunol; 1995 Jul; 25(7):1972-9. PubMed ID: 7621873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms.
    Vos Q; Lees A; Wu ZQ; Snapper CM; Mond JJ
    Immunol Rev; 2000 Aug; 176():154-70. PubMed ID: 11043775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity.
    Lin X; Tian H; Xianmin M
    Med Hypotheses; 2011 Mar; 76(3):339-42. PubMed ID: 21075543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.